StockData
Greenwich LifeSciences, Inc. logo

Greenwich LifeSciences, Inc. (GLSI) stock

GLSINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 6/30
$19.25−0.54 (-2.73%)

Close on Nov 20, 2026Market cap $282.56MP/E –Yield –

Greenwich LifeSciences free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Greenwich LifeSciences

Greenwich LifeSciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Greenwich LifeSciences figures

See a number that looks wrong?